Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Comparison of the Low Toxicity Tecam Conditioning Regimen to BEAM in Patients with Lymphoma Requiring Autologous Stem Cell Transplantation

Dana Rosenberg, MD, Erel Joffe, MDMSc, Uri Rozovski, MD, Chava Perry, MDPhD, Ilya Kirgner, MD, Svetlana Trestman, MD, Odelia Gur, Freddy Aviv, MD, Nadav Sarid, MD, Albert Kolomansky, MD, Lily Gepstein, Yair Herishanu, MD, Elizabeth Naparstek, MD

Blood (2015) 126 (23): 3188.

https://doi.org/10.1182/blood.V126.23.3188.3188

Published: 2015

Journal Articles

Efficacy and Safety of Autologus Hematopoietic Cell Transplantation in Elderly Patients with Multiple Myeloma: A Retrospective Israeli Multi-Site Cohort Study

Yael C Cohen, MD, Tsila Zuckerman, MD, Moshe Yeshurun, MD, Galit Perez, MD, Hila Magen, MD, Israel Henig, MD, Itai Levi, MD, Liat Shargian, Svetlana Trestman, MD, Uri Rouvio, MD, Elizabeth Naparstek, MD, Eti Ganon-Elazar, PhD, Irit Avivi, MD, Ron Ram, MD

Blood (2014) 124 (21): 3989.

https://doi.org/10.1182/blood.V124.21.3989.3989

Published: 2014

Journal Articles

New Xenograft Method For Studying Leukemia and Drug Response In Turkey Embryos

Varda R Deutsch, PhD, Sigi Kay, PhD, Yona Farnoushi, MSc, Erez Matalon, MSc, Tal Ohayon, MSc, Shoshana Baron, Hila Jan, MSc, Elizabeth Naparstek, MD, Michal Cipok, PhD

Blood (2013) 122 (21): 3973.

https://doi.org/10.1182/blood.V122.21.3973.3973

Published: 2013

Journal Articles

Second Allogeneic Stem Cell Transplantation (AlloSCT) In Patients With Relapsed Lymphoma After First Allosct. A Retrospective Study Of The EBMT Lymphoma Working Party

Kristin Horstmann, Ariane Boumendil, PhD, Herve Finel, Jane F. Apperley, MBChB, FRCP, FRCPath, Fabio Ciceri, MD, Juergen Finke, MD, Achiel Van Hoof, Norbert Ifrah, MD, Slawomira Kyrcz-Krzemien, MD, Gustavo Milone, Ghulam J Mufti, FRCP, FRCPath, Elizabeth Naparstek, MD, Reuven Or, MD, Nigel H Russell, MD, Peter Dreger, MD

Blood (2013) 122 (21): 4632.

https://doi.org/10.1182/blood.V122.21.4632.4632

Published: 2013

Journal Articles

Absolute Monocyte Count Trichotomizes Chronic Lymphocytic Leukemia Into High Risk Patients With Immune Dysregulation, Disease Progression and Poor Survival

Yair Herishanu, MD, Sigi Kay, PhD, Varda Deutsch, PhD, Jonathan Ben-Ezra, MD, Elizabeth Naparstek, MD, Chava Perry, MD/PhD, Ben-Zion Katz, PhD

Blood (2013) 122 (21): 4724.

https://doi.org/10.1182/blood.V122.21.4724.4724

Published: 2013

Journal Articles

Heparin-Induced Thrombocytopenia: A Rapid, Reliable and Practical, Functional Flow-Cytometric Assay

Varda Deutsch, PhD, Michal Cipok, PhD, Sigi Kay, PhD, Yvette Levy, Shoshana Bar On, Ilya Kirgner, MD, Elizabeth Naparstek, MD, Aaron Tomer, MD

Blood (2013) 122 (21): 1130.

https://doi.org/10.1182/blood.V122.21.1130.1130

Published: 2013

Journal Articles

Divergence in CD19-Mediated Signaling Unfolds Intra-Clonal Diversity in Chronic Lymphocytic Leukemia Which Correlates with Disease Progression

Yair Herishanu, MD, Sigi Kay, PhD, Nili Dezorella, MSc, Chava Perry, MD/PhD, Varda Deutsch, PhD, Aaron Polliack, MD, Elizabeth Naparstek, MD, Benzion Katz, PhD

Blood (2012) 120 (21): 4570.

https://doi.org/10.1182/blood.V120.21.4570.4570

Published: 2012

Journal Articles

Prognostic Significance of the FISH Panel for Patients with Multiple Myeloma

Rachel Rothman, Nadia Voskoboinik, Yair Herishanu, MD, Avi Orr-Urtreger, Elizabeth Naparstek, MD, Svetlana Trestman, MD

Blood (2012) 120 (21): 5001.

https://doi.org/10.1182/blood.V120.21.5001.5001

Published: 2012

Journal Articles

Increased CD39 Expression on CD4+ T-Lymphocytes Has Clinical and Prognostic Significance in Chronic Lymphocytic Leukemia,

Yair Herishanu, MD, Inbal Hazan-Hallevi, PhD, Sigi Kay, PhD, Varda Deutsch, PhD, Aaron Polliack, MD, Elizabeth Naparstek, MD, Chava Perry, MD/PhD

Blood (2011) 118 (21): 3895.

https://doi.org/10.1182/blood.V118.21.3895.3895

Published: 2011

Journal Articles

Intra-Clonal Diversity Identified by CD19-Mediated Signaling Correlates with Disease Progression In Chronic Lymphocytic Leukemia (CLL)

Yair Herishanu, MD, Sigi Kay, PhD, Nili Dezorella, BSc., Inbal Hazan-Hallevi, PhD, Svetlana Trestman, MD, Chava Perry, MD/PhD, Varda Deutsch Deutsch, PhD, Aaron Polliack, MD, Elizabeth Naparstek, MD, Ben-Zion Katz, PhD

Blood (2010) 116 (21): 3577.

https://doi.org/10.1182/blood.V116.21.3577.3577

Published: 2010

Journal Articles

A New Xenograft Model for Studying Multiple Myeloma and Drug Response

Varda Deutsch, PhD, Yona Farnoushi, MSc, Michal Cipok, PhD, Sigi Kay, PhD, Elizabeth Naparstek, MD, Ronald Goldstein, PhD

Blood (2010) 116 (21): 4073.

https://doi.org/10.1182/blood.V116.21.4073.4073

Published: 2010

Journal Articles

The Predictive Value of TP53 FISH Analysis for Treatment Response and Survival in Cytogenetic Subgroups of AML Patients.

Sigal Tavor, MD, Rachel Rothman, PhD, Tamar Golan, PhD, Nadia Voskoboinik, PhD, Ruth Shomrat, PhD, Avi Orr-Urtreger, MD, PhD, Elizabeth Naparstek, MD

Blood (2009) 114 (22): 2617.

https://doi.org/10.1182/blood.V114.22.2617.2617

Published: 2009

Journal Articles

A New In Vivo Platform for Studying the Growth of Hematopoietic Cancer Initiating Blood Cells and Response to Therapy.

Michal Cipok, PhD, Yona Farnoushi, BSc, Sigi Kay, PhD, Igor Grinberg, MSc, Arbel Reis, MSc, Elizabeth Naparstek, MD, Ronald S Goldstein, Varda R Deutsch, PhD

Blood (2009) 114 (22): 4142.

https://doi.org/10.1182/blood.V114.22.4142.4142

Published: 2009

Journal Articles

Mimicking the Hematopoietic Niche Microenvironment Provides a Novel Strategy for Expansion of Hematopoietic and Megakaryocyte-Progenitor Cells from Cord Blood

Varda R Deutsch, PhD, Einav Hubel, MSc, Sigi Kay, PhD, Tal Ohayon, MSc, Ben-Zion Katz, PhD, Elizabeth Naparstek, MD, Dan Grisaru, MD

Blood (2008) 112 (11): 3462.

https://doi.org/10.1182/blood.V112.11.3462.3462

Published: 2008

Journal Articles

Improvement of Oxidative Stress Parameters in MDS Patients with Iron Overload Treated with Deferasirox

Eliezer Rachmilewitz, M.D., Drorit Merkel, M.D., Hussam Ghoti, M.D, Johnny Amer, Ph.D, Arnon Nagler, M.D., Galit Perez-Avraham, M.D, Sigal Grisariu, M.D., Elizabeth Naparstek, M.D, Aliza Ackerstein, M.Sc, Eitan Fibach, Ph.D

Blood (2008) 112 (11): 2675.

https://doi.org/10.1182/blood.V112.11.2675.2675

Published: 2008

Journal Articles

The CXCR4 Antagonist AMD3100 Impairs Survival of AML Cells and Induces Their Differentiation.

Sigal Tavor, MD, Manny Eisenbach, Jasmine Jacob-Hirsch, Tammar Golan, PhD, Isabelle Petit, PhD, Katz Ben-Zion, PhD, Sigi Kay, PhD, Shoshana Baron, Ninette Amariglio, PhD, Varda Deutsch, PhD, Elizabeth Naparstek, MD, Gideon Rechavi, MD, PhD

Blood (2008) 112 (11): 1621.

https://doi.org/10.1182/blood.V112.11.1621.1621

Published: 2008

Journal Articles

Soluble CD14 Protects Human Lymphocytes from Apoptosis

Elizabeth Naparstek, M.D, Benjamin Sredni, PhD, Eti Zigman, Gali Senyor, Boris Tartakovsky, PhD

Blood (2008) 112 (11): 2566.

https://doi.org/10.1182/blood.V112.11.2566.2566

Published: 2008

Journal Articles

T-Cell Abnormalities in Patients with Myelodysplastic Syndromes: Improved Immunological Functions in Patients Treated with Recombinant Erythropoietin.

Sara Prutchi-Sagiv, MSc, Nataliya Golishevski, MD, Odelia Katz, MSc, Howard S. Oster, MD PhD, Elizabeth Naparstek, MD, Michael Hoffman, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2006) 108 (11): 2675.

https://doi.org/10.1182/blood.V108.11.2675.2675

Published: 2006

Journal Articles

Inhibition of Elastase or SDF-1/CXCR4 Axis Promotes Differentiation of Human AML Cells.

Sigal Tavor, MD, Jasmine Jacob-Hirsch, MSc, Manny Eisenbach, MSc, Sigi Kay, PhD, Shoshana Baron, Ninette Amariglio, PhD, Elizabeth Naparstek, MD, Gideon Rechavi, MD, PhD

Blood (2006) 108 (11): 1891.

https://doi.org/10.1182/blood.V108.11.1891.1891

Published: 2006

Journal Articles

Functional CXCR4 Expressing Microparticles and SDF-1 Correlate with Circulating AML Cell Counts.

Alexander Kalinkovich, MD, PhD, Sigal Tavor, MD, Abraham Avigdor, MD, Joy Kahn, PhD, Alexander Brill, PhD, Isabelle Petit, PhD, Polina Goichberg, PhD, Melania Tesio, M.Sc, Neta Netzer, Ms, Elizabeth Naparstek, Izhar Hardan, MD, Arnon Nagler, Igor Resnick, MD, Alexander Tsimanis, PhD, Tsvee Lapidot

Blood (2006) 108 (11): 4375.

https://doi.org/10.1182/blood.V108.11.4375.4375

Published: 2006

NARROW

Comparison of the Low Toxicity Tecam Conditioning Regimen to BEAM in Patients with Lymphoma Requiring Autologous Stem Cell Transplantation

Efficacy and Safety of Autologus Hematopoietic Cell Transplantation in Elderly Patients with Multiple Myeloma: A Retrospective Israeli Multi-Site Cohort Study

New Xenograft Method For Studying Leukemia and Drug Response In Turkey Embryos

Second Allogeneic Stem Cell Transplantation (AlloSCT) In Patients With Relapsed Lymphoma After First Allosct. A Retrospective Study Of The EBMT Lymphoma Working Party

Absolute Monocyte Count Trichotomizes Chronic Lymphocytic Leukemia Into High Risk Patients With Immune Dysregulation, Disease Progression and Poor Survival

Heparin-Induced Thrombocytopenia: A Rapid, Reliable and Practical, Functional Flow-Cytometric Assay

Divergence in CD19-Mediated Signaling Unfolds Intra-Clonal Diversity in Chronic Lymphocytic Leukemia Which Correlates with Disease Progression

Prognostic Significance of the FISH Panel for Patients with Multiple Myeloma

Increased CD39 Expression on CD4+ T-Lymphocytes Has Clinical and Prognostic Significance in Chronic Lymphocytic Leukemia,

Intra-Clonal Diversity Identified by CD19-Mediated Signaling Correlates with Disease Progression In Chronic Lymphocytic Leukemia (CLL)

A New Xenograft Model for Studying Multiple Myeloma and Drug Response

The Predictive Value of TP53 FISH Analysis for Treatment Response and Survival in Cytogenetic Subgroups of AML Patients.

A New In Vivo Platform for Studying the Growth of Hematopoietic Cancer Initiating Blood Cells and Response to Therapy.

Mimicking the Hematopoietic Niche Microenvironment Provides a Novel Strategy for Expansion of Hematopoietic and Megakaryocyte-Progenitor Cells from Cord Blood

Improvement of Oxidative Stress Parameters in MDS Patients with Iron Overload Treated with Deferasirox

The CXCR4 Antagonist AMD3100 Impairs Survival of AML Cells and Induces Their Differentiation.

Soluble CD14 Protects Human Lymphocytes from Apoptosis

T-Cell Abnormalities in Patients with Myelodysplastic Syndromes: Improved Immunological Functions in Patients Treated with Recombinant Erythropoietin.

Inhibition of Elastase or SDF-1/CXCR4 Axis Promotes Differentiation of Human AML Cells.

Functional CXCR4 Expressing Microparticles and SDF-1 Correlate with Circulating AML Cell Counts.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only